Comera Life Sciences Holdings, Inc. (CMRA)

OTCMKTS: CMRA · Delayed Price · USD

0.0250

-0.0001 (-0.40%)

Jul 2, 2024, 9:53 AM EDT - Market closed

CMRA Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020
Net Income	-24.04	-5.29	-2.13
Depreciation & Amortization	0.09	0.09	0.09
Share-Based Compensation	0.38	1.11	0.1
Other Operating Activities	13.8	0.33	0.13
Operating Cash Flow	-9.77	-3.76	-1.8
Capital Expenditures	-0.03	-0.14	-0.01
Investing Cash Flow	-0.03	-0.14	-0.01
Common Stock Issued	0.83	0	1.39
Other Financing Activities	4.41	10.28	0.16
Financing Cash Flow	5.24	10.28	1.55
Net Cash Flow	-4.56	6.38	-0.26
Free Cash Flow	-9.8	-3.9	-1.82
Free Cash Flow Margin	-1547.99%	-1219.38%	-410.11%
Free Cash Flow Per Share	-0.94	-0.20	-0.10

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.